New gene editing strategies developed for Duchenne muscular dystrophy
Same drug can have opposite effects on memory according to sexual differences
3 May 2021Why we remember more by reading—especially print—than from audio or video
3 May 2021New gene editing strategies developed for Duchenne muscular dystrophy
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section of the dystrophin protein that is missing in many DMD patients. The approach, described online today in the journal Science Advances, could lead to a treatment for DMD and inform the treatment of other inherited diseases.
